NVO logo

Novo Nordisk A/S (NVO) Cash From Investing

Annual CFI:

-$18.69B-$12.32B(-193.51%)
December 31, 2024

Summary

  • As of today, NVO annual cash from investing is -$18.69 billion, with the most recent change of -$12.32 billion (-193.51%) on December 31, 2024.
  • During the last 3 years, NVO annual cash from investing has fallen by -$13.67 billion (-272.09%).
  • NVO annual cash from investing is now -52292.03% below its all-time high of -$35.68 million, reached on December 1, 1980.

Performance

NVO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Quarterly CFI:

-$2.11B-$1.17B(-123.80%)
June 1, 2025

Summary

  • As of today, NVO quarterly cash from investing is -$2.11 billion, with the most recent change of -$1.17 billion (-123.80%) on June 1, 2025.
  • Over the past year, NVO quarterly cash from investing has increased by +$900.07 million (+29.93%).
  • NVO quarterly cash from investing is now -465.88% below its all-time high of $575.87 million, reached on March 31, 2024.

Performance

NVO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFI:

-$19.31B+$900.07M(+4.45%)
June 1, 2025

Summary

  • As of today, NVO TTM cash from investing is -$19.31 billion, with the most recent change of +$900.07 million (+4.45%) on June 1, 2025.
  • Over the past year, NVO TTM cash from investing has dropped by -$12.82 billion (-197.63%).
  • NVO TTM cash from investing is now -136348.41% below its all-time high of $14.17 million, reached on June 30, 2004.

Performance

NVO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-193.5%+29.9%-197.6%
3Y3 Years-272.1%-245.9%-295.1%
5Y5 Years-981.6%-943.4%-909.9%

NVO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-431.0%at low-465.9%+84.0%-448.6%+4.5%
5Y5-Year-981.6%at low-465.9%+84.0%-909.9%+4.5%
All-TimeAll-Time>-9999.0%at low-465.9%+84.0%>-9999.0%+4.5%

NVO Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.11B(-123.8%)
-$19.31B(+4.5%)
Mar 2025
-
-$941.45M(+92.9%)
-$20.21B(-8.1%)
Dec 2024
-$18.69B(-193.5%)
-$13.20B(-331.2%)
-$18.69B(-145.1%)
Sep 2024
-
-$3.06B(-1.8%)
-$7.63B(-17.6%)
Jun 2024
-
-$3.01B(-622.2%)
-$6.49B(-34.2%)
Mar 2024
-
$575.87M(+127.0%)
-$4.83B(+24.1%)
Dec 2023
-$6.37B(-80.9%)
-$2.14B(-11.2%)
-$6.37B(-3.3%)
Sep 2023
-
-$1.92B(-41.9%)
-$6.16B(-24.9%)
Jun 2023
-
-$1.35B(-41.3%)
-$4.94B(-17.8%)
Mar 2023
-
-$958.18M(+50.4%)
-$4.19B(-19.1%)
Dec 2022
-$3.52B(+29.9%)
-$1.93B(-178.6%)
-$3.52B(+27.3%)
Sep 2022
-
-$693.02M(-13.8%)
-$4.84B(+1.0%)
Jun 2022
-
-$609.07M(-111.8%)
-$4.89B(-3.0%)
Mar 2022
-
-$287.52M(+91.2%)
-$4.75B(+5.5%)
Dec 2021
-$5.02B(-46.3%)
-$3.25B(-339.0%)
-$5.02B(-33.3%)
Sep 2021
-
-$740.52M(-58.3%)
-$3.77B(+4.6%)
Jun 2021
-
-$467.94M(+17.1%)
-$3.95B(-7.2%)
Mar 2021
-
-$564.42M(+71.7%)
-$3.69B(-7.4%)
Dec 2020
-$3.43B(-98.7%)
-$2.00B(-116.1%)
-$3.43B(-79.6%)
Sep 2020
-
-$923.59M(-357.4%)
-$1.91B(-41.2%)
Jun 2020
-
-$201.93M(+35.2%)
-$1.35B(+14.2%)
Mar 2020
-
-$311.85M(+34.3%)
-$1.58B(+8.7%)
Dec 2019
-$1.73B(+9.8%)
-$474.68M(-29.9%)
-$1.73B(+8.5%)
Sep 2019
-
-$365.49M(+14.2%)
-$1.89B(+4.2%)
Jun 2019
-
-$426.10M(+7.8%)
-$1.97B(-1.0%)
Mar 2019
-
-$462.03M(+27.2%)
-$1.95B(-1.9%)
Dec 2018
-$1.92B(-91.4%)
-$634.60M(-41.7%)
-$1.92B(-8.2%)
Sep 2018
-
-$447.96M(-10.3%)
-$1.77B(-9.0%)
Jun 2018
-
-$406.04M(+4.8%)
-$1.62B(-22.5%)
Mar 2018
-
-$426.46M(+12.9%)
-$1.33B(-32.5%)
Dec 2017
-$1.00B(+1.2%)
-$489.43M(-61.8%)
-$1.00B(-9.5%)
Sep 2017
-
-$302.44M(-182.0%)
-$913.18M(+9.6%)
Jun 2017
-
-$107.25M(-6.0%)
-$1.01B(-15.8%)
Mar 2017
-
-$101.20M(+74.8%)
-$872.88M(+13.8%)
Dec 2016
-$1.01B(-11.7%)
-$402.28M(-0.7%)
-$1.01B(+22.4%)
Sep 2016
-
-$399.68M(-1419.9%)
-$1.31B(+6.9%)
Jun 2016
-
$30.28M(+112.6%)
-$1.40B(+1.7%)
Mar 2016
-
-$241.03M(+65.3%)
-$1.43B(-57.2%)
Dec 2015
-$906.61M(-146.8%)
-$694.94M(-40.2%)
-$906.61M(-84.9%)
Sep 2015
-
-$495.68M(-8291.8%)
-$490.39M(-166.9%)
Jun 2015
-
$6.05M(-97.8%)
-$183.73M(-10.9%)
Mar 2015
-
$277.96M(+199.7%)
-$165.69M(+54.9%)
Dec 2014
-$367.27M(+25.6%)
-$278.72M(-47.5%)
-$367.27M(-98.8%)
Sep 2014
-
-$189.02M(-884.6%)
-$184.73M(+47.0%)
Jun 2014
-
$24.09M(-68.5%)
-$348.63M(-0.3%)
Mar 2014
-
$76.38M(+179.4%)
-$347.69M(+29.6%)
Dec 2013
-$493.64M(+29.7%)
-$96.18M(+72.7%)
-$493.64M(+27.0%)
Sep 2013
-
-$352.92M(-1510.2%)
-$676.42M(-7.6%)
Jun 2013
-
$25.03M(+136.0%)
-$628.82M(-17.7%)
Mar 2013
-
-$69.57M(+75.1%)
-$534.03M(+24.0%)
Dec 2012
-$702.31M(-8.8%)
-$278.96M(+8.6%)
-$702.31M(+21.6%)
Sep 2012
-
-$305.32M(-354.8%)
-$895.37M(-27.4%)
Jun 2012
-
$119.81M(+150.4%)
-$702.55M(+18.7%)
Mar 2012
-
-$237.84M(+49.6%)
-$864.24M(-33.9%)
Dec 2011
-$645.67M
-$472.03M(-319.6%)
-$645.67M(+20.9%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$112.50M(-168.7%)
-$815.90M(+4.9%)
Jun 2011
-
-$41.87M(-117.3%)
-$857.83M(+9.9%)
Mar 2011
-
-$19.27M(+97.0%)
-$952.23M(+4.1%)
Dec 2010
-$992.74M(-73.5%)
-$642.26M(-315.9%)
-$992.74M(-71.7%)
Sep 2010
-
-$154.43M(-13.3%)
-$578.29M(-0.7%)
Jun 2010
-
-$136.27M(-127.9%)
-$574.09M(-6.8%)
Mar 2010
-
-$59.79M(+73.8%)
-$537.57M(+6.0%)
Dec 2009
-$572.14M(-87.8%)
-$227.81M(-51.6%)
-$572.14M(-43.7%)
Sep 2009
-
-$150.22M(-50.6%)
-$398.28M(-16.8%)
Jun 2009
-
-$99.75M(-5.7%)
-$340.96M(+1.0%)
Mar 2009
-
-$94.37M(-74.9%)
-$344.51M(-13.1%)
Dec 2008
-$304.59M(+44.5%)
-$53.94M(+41.9%)
-$304.59M(+38.8%)
Sep 2008
-
-$92.90M(+10.1%)
-$498.08M(+3.7%)
Jun 2008
-
-$103.30M(-89.7%)
-$517.44M(+1.3%)
Mar 2008
-
-$54.45M(+78.0%)
-$524.43M(+4.4%)
Dec 2007
-$548.58M(-29.5%)
-$247.43M(-120.4%)
-$548.58M(-25.0%)
Sep 2007
-
-$112.26M(-1.8%)
-$438.83M(+5.9%)
Jun 2007
-
-$110.30M(-40.3%)
-$466.39M(+3.6%)
Mar 2007
-
-$78.60M(+42.9%)
-$483.61M(-14.2%)
Dec 2006
-$423.55M(+48.3%)
-$137.67M(+1.5%)
-$423.55M(+34.9%)
Sep 2006
-
-$139.82M(-9.6%)
-$650.23M(+7.9%)
Jun 2006
-
-$127.52M(-587.9%)
-$705.70M(+0.5%)
Mar 2006
-
-$18.54M(+94.9%)
-$709.08M(+13.4%)
Dec 2005
-$818.57M(-145.0%)
-$364.35M(-86.6%)
-$818.57M(-24.9%)
Sep 2005
-
-$195.30M(-49.2%)
-$655.28M(-7.9%)
Jun 2005
-
-$130.90M(-2.2%)
-$607.23M(-78.5%)
Mar 2005
-
-$128.03M(+36.3%)
-$340.21M(-1.8%)
Dec 2004
-$334.13M(+5.0%)
-$201.05M(-36.5%)
-$334.13M(-151.1%)
Sep 2004
-
-$147.25M(-208.2%)
-$133.08M(-1039.0%)
Jun 2004
-
$136.13M(+211.6%)
$14.17M(+111.6%)
Mar 2004
-
-$121.95M
-$121.95M
Dec 2003
-$351.79M(+36.8%)
-
-
Dec 2002
-$556.33M(-12.1%)
-
-
Dec 2001
-$496.25M(-57.8%)
-
-
Dec 2000
-$314.55M(-18.2%)
-
-
Dec 1999
-$266.19M(+16.8%)
-
-
Dec 1998
-$319.77M(+13.4%)
-
-
Dec 1997
-$369.24M(-7.7%)
-
-
Dec 1996
-$342.89M(-89.6%)
-
-
Dec 1995
-$180.88M(+39.7%)
-
-
Dec 1994
-$300.09M(+25.0%)
-
-
Dec 1993
-$400.24M(-12.4%)
-
-
Dec 1992
-$356.09M(-46.4%)
-
-
Dec 1991
-$243.17M(-21.8%)
-
-
Dec 1990
-$199.63M(-49.1%)
-
-
Dec 1989
-$133.92M(-15.6%)
-
-
Dec 1988
-$115.84M(-0.9%)
-
-
Dec 1987
-$114.80M(-18.3%)
-
-
Dec 1986
-$97.01M(-50.1%)
-
-
Dec 1985
-$64.63M(-5.8%)
-
-
Dec 1984
-$61.06M(+0.8%)
-
-
Dec 1983
-$61.52M(-3.7%)
-
-
Dec 1982
-$59.35M(-39.6%)
-
-
Dec 1981
-$42.52M(-19.2%)
-
-
Dec 1980
-$35.68M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash from investing?
  • What is the all-time high annual cash from investing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual cash from investing year-on-year change?
  • What is Novo Nordisk A/S quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly cash from investing year-on-year change?
  • What is Novo Nordisk A/S TTM cash from investing?
  • What is the all-time high TTM cash from investing for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM cash from investing year-on-year change?

What is Novo Nordisk A/S annual cash from investing?

The current annual cash from investing of NVO is -$18.69B

What is the all-time high annual cash from investing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash from investing is -$35.68M

What is Novo Nordisk A/S annual cash from investing year-on-year change?

Over the past year, NVO annual cash from investing has changed by -$12.32B (-193.51%)

What is Novo Nordisk A/S quarterly cash from investing?

The current quarterly cash from investing of NVO is -$2.11B

What is the all-time high quarterly cash from investing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash from investing is $575.87M

What is Novo Nordisk A/S quarterly cash from investing year-on-year change?

Over the past year, NVO quarterly cash from investing has changed by +$900.07M (+29.93%)

What is Novo Nordisk A/S TTM cash from investing?

The current TTM cash from investing of NVO is -$19.31B

What is the all-time high TTM cash from investing for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash from investing is $14.17M

What is Novo Nordisk A/S TTM cash from investing year-on-year change?

Over the past year, NVO TTM cash from investing has changed by -$12.82B (-197.63%)
On this page